P/E ratio for Smith & Nephew (SNN)
P/E ratio as of June 2024 (TTM): 22.3
According to Smith & Nephew 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 22.2995. At the end of 2013 the company had a P/E ratio of 23.2.
P/E ratio history for Smith & Nephew from 2001 to 2014
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2013 | 23.2 | 69.1% |
| 2012 | 13.7 | -6.9% |
| 2011 | 14.8 | -2.9% |
| 2010 | 15.2 | -20.87% |
| 2009 | 19.2 | 26.58% |
| 2008 | 15.2 | -54.84% |
| 2007 | 33.6 | 154.1% |
| 2006 | 13.2 | 1347.77% |
| 2005 | 0.9131 | -99.14% |
| 2004 | 106 | 16.14% |
| 2003 | 91.0 | 44.53% |
| 2002 | 63.0 | -75.49% |
| 2001 | 257 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 10.3 | -53.75% | 🇺🇸 USA |
 Boston Scientific BSX | 91.5 | 310.16% | 🇺🇸 USA |
 Edwards Lifesciences EW | 37.4 | 67.72% | 🇺🇸 USA |
 Stryker Corporation SYK | 50.0 | 124.23% | 🇺🇸 USA |
 Orthofix Medical
OFIX | -3.89 | -117.42% | 🇺🇸 USA |
 CONMED CNMD | 39.8 | 78.62% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.